Pharmafile Logo

Maximize Conference Impact Virtually – Engaging Your Advisors Creatively

July 10, 2025 |  

Extend the impact of scientific conferences! Discover how to creatively empower your advisors to share patient cases and evidence, sparking rich discussions on clinical implications and research questions. Drive deeper engagement post-congress!

Transform your post-conference engagement and extend the life of valuable insights. Explore innovative ways to leverage virtual platforms for congress coverage and post-conference engagement initiatives. Empower your advisors to share patient cases, digest emerging evidence from sessions, and spark deep discussions on data significance, clinical implications, and unanswered research questions. Learn how to foster ownership and generate rich, ongoing dialogue long after the live event concludes.

  1. Congress Coverage and Post-Conference Engagement Initiatives
    • Enable advisors to submit patient cases or evidence digests from live conferences.
    • Facilitate thought-provoking discussions on data, clinical implications, and research questions.
    • Empower advisors to moderate their own questions, fostering ownership and deeper engagement.
    • Extend the impact of conference sessions through sustained virtual dialogue.

For more creative ways to engage your advisors, visit: https://www.impetusdigital.com/2019/11/15/top-10-creative-ways-to-engage-your-advisors/

Learn more about Impetus Digital’s solutions: www.impetusdigital.com

Schedule a consultation: https://meetwithimpetus.com/

Stay connected:

This content was provided by Impetus Digital

Company Details

 Latest Content from  Impetus Digital 

Top 10 Tips to Increase Engagement During Virtual Events

Natalie Yeadon shares her top tips for making your virtual events engaging and interactive

How Patient Advocacy Can Positively Disrupt Healthcare

Seth Rotberg, Patient Recruitment Manager at WEGO Health & Co-Founder of Our Odyssey, shares his views on how to empower rare disease patients, improve clinical trials, and move towards a...

Leaders in Pharma: Danielle Portnik

In this episode of Impetus Digital's Leaders in Pharma podcast, I sit down with Danielle Portnik. She is currently the Regional Business Director for International with Ambry Genetics.

Leaders in Pharma: Samir Vattompadam

In the inaugural episode of Impetus Digital's Leaders in Pharma podcast, I sit down with Samir Vattompadam. Samir is currently Vice President, Program Executive for EQRx.

Building Better Access to Pediatric Care Through Telehealth

Jeannie Chen, Head of Clinical Operations and People at Hazel Health, shares her insights on telemedicine and virtual care as means to improve healthcare access and equity among school-aged children....

When Wireless Technology Meets Drug Delivery

Robert Niichel, Founder/CEO of SmartTab, explores the concept of personalized wireless drug delivery, including its advantages, barriers, and current status. We also discuss the future of digital medicine, the Internet...

Effective Leadership During & After the COVID-19 Pandemic

Carol Stiff, Head of Canada at Santen, delves into what effective leadership looks like before, during, and after COVID-19; challenges brought on by the pandemic; the importance of developing partnerships...

InSite Events™ National Pharma Meeting: A Customer Story

How our client leveraged Impetus Digital’s white-glove service, 360° coverage and care, and award-winning InSite Events™ platform to successfully transfer their annual national meeting online.

Shaping the Future of Medicine, Science, and Technology

Dr. José Morey, CEO and Founder of Ad Astra Media, Chief Medical Innovation Officer at Liberty BioSecurity, and the world’s first “intergalactic doctor” discusses AI, space medicine, human augmentation, and...

Advancing the Scientific Understanding of Medical Cannabis Through Real-Time User Data

David Berg, President and CTO of Strainprint, explores the current state of the medical cannabis industry in Canada and overseas and how Strainprint is bringing innovation to the industry. He...